The novel radical scavenger IAC is effective in preventing and protecting against post-ischemic brain damage in Mongolian gerbils

Journal of the Neurological Sciences

Volumn 290, Issue 1-2, 2010, Pages 90-95

  Canistro, Donatella ^a   Affatato, Alessandra A ^a   Soleti, Antonio ^b   Mollace, Vincenzo ^c,d   Muscoli, Carolina ^c,d   Sculco, Francesca ^c   Sacco, Iolanda ^c   Visalli, Valeria ^c   Bonamassa, Barbara ^a   Martano, Manuela ^b   Iannone, Michelangelo ^c,d   Sapone, Andrea ^a   Paolini, Moreno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Medestea Research   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Bilateral common carotid artery occlusion (BCCO); bis(1 hydroxy 2,2,6,6 tetramethyl 4 piperidinyl) decandioate (IAC); Brain damage; Ischemia reperfusion; Neuroprotection; Oxidative stress

Indexed keywords

BIS(1 HYDROXY 2,2,6,6 TETRAMETHYL 4 PIPERIDYNYL) DECANDIOATE; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL VIABILITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; MOLECULAR WEIGHT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN DAMAGE, CHRONIC; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID STENOSIS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; GERBILLINAE; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PIPERIDINES; TREATMENT OUTCOME;

EID: 75049084106     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.10.023     Document Type: Article

References (59)

1. Levi D.E., Caronna J.J., Singer B.H., Lapinski R.H., Frydman H., and Plum F. Predicting outcome from hypoxic-ischemic coma. JAMA 253 (1985) 1420-1426
2. Pulsinelli W.A., Brady J.N., Marchick M.R., Bourdi M., George J.W., Radonovich M.F., et al. A protective role for cycloxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14 (1982) 1620-1628
3. Kirino T. Delayed neuronal death. Neuropathology 20 (2000) S95-97 Suppl
4. Wolfe C.D. The impact of stroke. Br Med Bull 56 (2000) 275-286
5. Barber P.A., Auer R.N., Buchan A.M., and Sutherland G.R. Understanding and managing ischemic stroke. Can J Physiol Pharmacol 79 (2001) 283-296
6. Muscoli C., Mollace V., Wheatley J., Masini E., Ndengele M., Wang Z.Q., et al. Superoxide-mediated nitration of spinal manganese superoxide dismutase: a novel pathway in N-methyl-d-aspartate-mediated hyperalgesia. Pain 111 (2004) 96-103
7. Ajith T.A., Riji T., and Anu V. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor rosuvastatin. Clin Exp Pharmacol Physiol 35 (2008) 625-629
8. Cuzzocrea S., McDonald M.C., Mazzon E., Siriwardena D., Costantino G., Fulia F., et al. Effects of Tempol, a membrane permeable radical scavenger, in a gerbil model of brain injury. Brain Res 875 (2000) 96-106
9. Al-Omar F.A., Nagi M.N., and Abdulgadir M.M. Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochem Res 31 (2006) 611-618
10. Gaspar M.M., Boerman O.C., Laverman P., Corvo M.L., Storm G., and Cruz M.E. Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J Control Release 117 (2007) 186-195
11. Aston K., Rath N., Naik A., Slomczynska U., Schall O.F., and Riley D.P. Computer-aided design (CAD) of Mn (II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg Chem 40 (2001) 1779-1789
12. Mollace V., Iannone M., Muscoli C., Palma E., Granato T., Modesti A., et al. The protective effect of M40401, a superoxide dismutase mimetic, on post-ischemic brain damage in Mongolian gerbils. BMC Pharmacol 3 (2003) 8-16
13. Samlowski W.E., Petersen R., Cuzzocrea S., Macarthur H., Burton D., McGregor J.R., et al. A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Nat Med 9 (2003) 750-755
14. Perel P., Roberts I., Sena E., Wheble P., Briscole C., Sancercock P., et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334 (2007) 197-206
15. Novelli M., D'Aleo V., Lupi R., Paolini M., Soleti A., Marchetti P., et al. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Pancreas 35 (2007) e10-17
16. Lupi R., Del Guerra S., Bancarella R., Novelli M., Valgimigli L., Peduli G.F., et al. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab 33 (2007) 340-345
17. Valgimigli L., Pedulli G.F., and Paolini M. Measurement of oxidative stress by EPR radical-probe technique. Free Radic Biol Med 31 (2001) 708-716
18. Ohkawa H., Ohishi H., and Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
19. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239 (1982) 57-69
20. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239 (1982) 57-69
21. Colbourne F., Li H., and Buchan A.M. Continuing post-ischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 30 (1999) 662-668
22. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., and Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. PNAS USA 87 (1990) 5144-5147
23. Margaill I., Plotkine M., and Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39 (2005) 429-443
24. Liu P.K., Grossman R.G., Hsu C.Y., and Robertson C.S. Ischemic injury and faulty gene transcripts in the brain. Trends Neurosci 24 (2001) 581-588
25. Chan P.H. Role of oxidants in ischemic brain damage. Stroke 27 (1996) 1124-1129
26. Knuckey N.W., Palm D., Primiano M., Epstein M.H., and Johanson C.E. N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke 26 (1995) 305-311
27. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21 (2001) 2-14
28. Candelario-Jalil E., Mhadu N.H., Ai-Dalain S.M., Martinez G., and Leon O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res 41 (2001) 233-241
29. Al-Nita D., Nita V., Spulber S., Moldovan M., Popa D.P., Zagrean A.M., et al. Oxidative damage following cerebral ischemia depends in reperfusion-a biochemical study in rat. J Cell Mol Med 5 (2001) 163-170
30. Al-Majed A.A., Al-Omar F.A., and Nagi M.N. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur J Pharmacol 543 (2006) 40-47
31. Homi H.M., Freitas J.J.S., Curi R., Velasco I.T., and Junior B.A.S. Changes in superoxide dismutase and catalase activities of rat brain regions during early global transient ischemia/reperfusion. Neurosci Lett 333 (2002) 37-40
32. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18 (1998) 205-213
33. Sheng H., Bart R.D., Oury T.D., Pearlstein R.D., Crapo J.D., and Warner D.S. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 88 (1999) 185-191
34. Nurmi A., Miettinen T.K., Puoliväli J., Pussinen R., Soleti A., Bagate K., et al. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia. Brain Res 1207 (2008) 174-181
35. Sena E., Wheble P., Sandercock P., and Macleod M. Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke 38 (2007) 388-394
36. Kuroda S., Tsuchidate R., Smith M.L., Maples K.R., and Siesjö B.K. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19 (1999) 778-787
37. van der Worp H.B., Kappelle L.J., Algra A., Bär P.R., Orgogozo J.M., Ringelstein E.B., et al. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke. Neurology 58 (2002) 133-135
38. Sydserff S.G., Borelli A.R., Green A.R., and Cross A.J. Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia. Brain Res 1035 (2002) 196-205
39. Salom J.B., Pérez-Asensio F.J., Burguete M.C., Marín N., Pitarch C., Torregrosa G., et al. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. Eur J Pharmacol 495 (2004) 55-62
40. Green A.R., and Ashwood T. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Curr Drug Targets CNS Neurol Disord 4 (2005) 109-118
41. Doggrell S.A. Nitrone spin on cerebral ischemia. Curr Opin Investig Drugs 7 (2006) 20-24
42. Koziol J.A., and Feng A.C. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke. Stroke 37 (2006) 2644-2647
43. Hill M.D. Stroke: the dashed hopes of neuroprotection. Lancet 6 (2007) 1-2
44. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 392 (1998) 559
45. Paolini M., Abdel-Rahman S.Z., Cantelli-Forti G., and Legator M.S. Chemoprevention or antichemoprevention? A salutary warning from the beta-carotene experience. J Natl Cancer Inst 93 (2001) 1110-1111
46. Louwerse E.S., Weverling G.W., Bossuyt P.M.M., Meyjes F.E.P., and de Jong V. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 52 (1995) 559-564
47. Andreassen O.A., Dedeoglu A., Klivenyi P., Beal M.F., and Bush A.I. N-acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. NeuroReport 11 (2000) 2491-2493
48. Desnuelle C., Dib M., Garrel C., and Favier A.A. A double-blind, placebo controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS Riluzole-Tocopherol Study Group. Amyotroph Lateral Scler Other Mot Neuron Disord 2 (2001) 9-18
49. Graf M., Ecker D., Horowski R., Kramer B., Riederer P., Gerlach M., et al. German vitamin E/ALS Study Group High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 113 (2005) 649-660
50. Orrell R.W., Lane R.J.M., and Ross M. Cochrane database of systematic reviews. Cochrane Database Syst Rev 1 (2007) CD002829
51. The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328 (1993) 176-183
52. Boothby L.A., and Doering P.L. Vitamin C and vitamin E for Alzheimer's disease. Anna Pharmacother 39 (2005) 2073-2080
53. Pham D.Q., and Plakogiannis R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann Pharmacother 39 (2005) 2065-2072
54. Weber C.A., and Ernst M.E. Antioxidants, supplements and Parkinson's disease. Ann Pharmacother 40 (2006) 935-938
55. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., Robinson J.S., and ACTS Study Group. Vitamins C and E and the risks of pre-eclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
56. Poston L., Brileym A.L., Seed P.T., Kelly F.J., and Shennan A.H. Vitamins In Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
57. Cho E., Hunter D.J., Spiegelman D., Albanes D., Beeson W.L., van den Brandt P.A., et al. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer 118 (2006) 970-978
58. Bleys J., Miller III E.R., Pastor-Barriuso R., Appel L.J., and Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 84 (2006) 880-887
59. Rak R., Chao D.L., Pluta R.M., Mitchell J.B., Oldfield E.H., and Watson J.C. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92 (2000) 646-651